Correspondencia
Réplica: Ivermectina en COVID-19. ¿Argumentum ad ignorantiam?
Reply to: Ivermectin in COVID-19. Argumentum ad ignorantiam?
M.L. López Reboiro, C. Sardiña González, J. López Castro
Servicio de Medicina Interna, Hospital Público de Monforte, Lugo, España
Leído
7404
Vecesse ha leído el artículo
1078
Total PDF
6326
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 5 | 0 | 5 |
| 2025 5 | 78 | 3 | 81 |
| 2025 4 | 95 | 1 | 96 |
| 2025 3 | 92 | 1 | 93 |
| 2025 2 | 96 | 0 | 96 |
| 2025 1 | 72 | 0 | 72 |
| 2024 12 | 87 | 2 | 89 |
| 2024 11 | 62 | 1 | 63 |
| 2024 10 | 90 | 2 | 92 |
| 2024 9 | 87 | 5 | 92 |
| 2024 8 | 86 | 0 | 86 |
| 2024 7 | 79 | 3 | 82 |
| 2024 6 | 127 | 2 | 129 |
| 2024 5 | 95 | 3 | 98 |
| 2024 4 | 86 | 0 | 86 |
| 2024 3 | 80 | 0 | 80 |
| 2024 2 | 68 | 10 | 78 |
| 2024 1 | 61 | 5 | 66 |
| 2023 12 | 58 | 7 | 65 |
| 2023 11 | 84 | 8 | 92 |
| 2023 10 | 61 | 9 | 70 |
| 2023 9 | 84 | 12 | 96 |
| 2023 8 | 49 | 3 | 52 |
| 2023 7 | 46 | 7 | 53 |
| 2023 6 | 56 | 9 | 65 |
| 2023 5 | 59 | 9 | 68 |
| 2023 4 | 58 | 7 | 65 |
| 2023 3 | 58 | 9 | 67 |
| 2023 2 | 45 | 11 | 56 |
| 2022 1 | 63 | 16 | 79 |
| 2022 12 | 82 | 13 | 95 |
| 2022 11 | 94 | 14 | 108 |
| 2022 10 | 107 | 23 | 130 |
| 2022 9 | 77 | 17 | 94 |
| 2022 8 | 90 | 29 | 119 |
| 2022 7 | 88 | 24 | 112 |
| 2022 6 | 93 | 20 | 113 |
| 2022 5 | 81 | 23 | 104 |
| 2022 4 | 94 | 22 | 116 |
| 2022 3 | 102 | 26 | 128 |
| 2022 2 | 83 | 22 | 105 |
| 2021 1 | 104 | 17 | 121 |
| 2021 12 | 105 | 24 | 129 |
| 2021 11 | 68 | 23 | 91 |
| 2021 10 | 80 | 26 | 106 |
| 2021 9 | 89 | 34 | 123 |
| 2021 8 | 54 | 18 | 72 |
| 2021 7 | 52 | 19 | 71 |
| 2021 6 | 76 | 23 | 99 |
| 2021 5 | 68 | 29 | 97 |
| 2021 4 | 267 | 62 | 329 |
| 2021 3 | 151 | 29 | 180 |
| 2021 2 | 143 | 17 | 160 |
| 2020 1 | 322 | 53 | 375 |
| 2020 12 | 148 | 28 | 176 |
| 2020 11 | 99 | 39 | 138 |
| 2020 10 | 262 | 36 | 298 |
| 2020 9 | 452 | 77 | 529 |
| 2020 8 | 376 | 54 | 430 |
| 2020 7 | 252 | 92 | 344 |
Mostrar todo
